ESR1 and breast carcinoma: Clinically, breast cancer is commonly classified into different subtypes based on a variety of immunohistochemical markers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER2), and tumor proliferation antigen (Ki-67), which are utilized to guide the diagnostic decisions and clinical treatment [4].